Maternal Opioid Misuse Model

The Centers for Medicare & Medicaid Services (CMS), through its Center for Medicare and Medicaid Innovation (Innovation Center), seeks applications to the Maternal Opioid Misuse (MOM) model. The MOM model is the next step in CMS' multi-pronged strate

The MOM model leverages Innovation Center authorities and state flexibility to address fragmentation in the care of pregnant and postpartum Medicaid beneficiaries with opioid use disorder. To foster integrated and coordinated care for the model population, CMS supports awardees to design and implement state-specific interventions through funding for 1) infrastructure and capacity development, 2) care delivery, and 3) milestones tied to key quality metrics. During the model's five-year performance period, responsibility for funding the care-delivery innovation has transitioned to states, with the ultimate goal of sustaining successful payment and care-delivery strategies through incorporation into their Medicaid programs. CMS currently funds eight renewable one-year cooperative agreements to State Medicaid agencies. No additional awards are anticipated.

State Medicaid agencies are eligible to apply for MOM model funding.

State Medicaid Agencies may apply for MOM model assistance.

The MOM model provides three distinct funding opportunities for awardees: • Implementation Funding will be available annually during each year of the model to support infrastructure and capacity-building. • Transition Funding will be available only during the Transition Period and only to support intake, assessment, and creation of a treatment plan (payment available once per pregnancy per beneficiary) and coordination, engagement, and referral activities (payment available on a monthly basis for up to 12 months for each beneficiary who receives these services) not otherwise covered by the State Plan. Model funds may not be used to supplant or duplicate existing funding sources. The state must take over these costs in alignment with its Coverage and Payment Strategy by Year 3 of the model. Transition Funding is restricted and not guaranteed. • Milestone Funding will be available during the Full Implementation Period based on an awardee's demonstrated performance on pre-determined quality milestones. Milestone Funding is restricted and not guaranteed. Applicants must describe in detail how they will use Implementation Funding and Transition Funding to implement the model. In addition to the detailed justifications for use of Implementation Funding and Transition Funding, each applicant should provide a plan for how Milestone Funding, if unrestricted, would be used to support the goals of the MOM model.

MOM model funding will be available on an annual basis to awardees for five years. The model will start in FY 2020 and end in FY 2024.

Applications will be forwarded to a review panel. The review panel will evaluate the proposals based on how well they address the evaluation criteria outlined in the NOFO. Successful applicants will receive a Notice of Award (NoA) signed and dated by the CMS Grants Management Officer that will set forth the amount of the award and other pertinent information. The award will also include standard Terms and Conditions. Applicants should be aware that special requirements could apply to cooperative agreement awards based on the particular circumstances of the effort to be supported and/or deficiencies identified by the review panel.

1. Successful applicants will receive a Notice of Award (NoA) signed and dated by the CMS Grants Management Officer that will set forth the amount of the award and other pertinent information. The award will also include standard Terms and Conditions. Applicant should be aware that special requirements could apply to cooperative agreement awards based on the particular circumstances of the effort to be supported and/or deficiencies identified by the review panel. 2. Award funds will be distributed through the Payment Management System.

The MOM NOFO was released in early 2019. Points of contact for the MOM Model can provide updated information when it is available.

6 months

Not Applicable. CMS reserves the right to approve or deny any or all proposals for funding. The Innovation Center's authorizing statute at 1115A(d)(2) of the Social Security Act states that there is no administrative or judicial review of the selection of organizations, sites, or participants to test models.